Pursuant to a resolution passed by shareholders on Oct. 19, 2026, the company has consolidated its capital on a one-new-for-49.6104-old basis. The name of the company has also been changed as detailed below.
Effective at the opening on Nov. 17, 2026, the common shares of Vimy Pharmaceuticals Corp. will commence trading on the TSX Venture Exchange and the common shares of Harmony Acquisitions Corp. will be delisted.
Effective at the opening of business on Nov. 17, 2026, the common shares of Vimy Pharmaceuticals will commence trading on the TSX Venture Exchange as a Tier 2 life sciences company. The NAICS number of the company is 325410.
Capitalization: unlimited number of common shares with no par value, of which 32,347,829 common shares are issued and outstanding
Escrow: 22,535,642
Transfer agent: Odyssey Trust Company
Trading symbol: VIMY (new)
Cusip No.: 918236 10 0 (new)
© 2026 Canjex Publishing Ltd. All rights reserved.